|

Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers

RECRUITINGPhase 2Sponsored by Institute of Oncology Ljubljana
Actively Recruiting
PhasePhase 2
SponsorInstitute of Oncology Ljubljana
Started2026-06-02
Est. completion2029-02
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This is a prospective, randomized, single-center clinical trial evaluating whether early prophylactic radiotherapy to high-risk asymptomatic or minimally symptomatic bone metastases reduces the 1-year rate of skeletal-related events (SREs) in patients with metastatic solid cancers. Patients will be randomized in a 1:1 ratio to receive either standard of care systemic therapy or observation, or prophylactic radiotherapy in addition to standard of care. The primary endpoint is the 1-year rate of SREs. Secondary endpoints include adverse events, quality of life, economic burden, pain-free survival, and overall survival.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥18 years
* Histologically confirmed solid malignancy
* Metastatic disease confirmed by imaging (CT, MRI, or PET-CT)
* Presence of up to five high-risk bone metastases
* High-risk bone metastases defined according to protocol criteria
* Asymptomatic or minimally symptomatic bone metastases (not requiring opioid analgesics)
* ECOG performance status 0-2
* Ability to provide written informed consent

Exclusion Criteria:

* Prior radiotherapy to the index bone metastases preventing safe treatment planning
* Symptomatic bone metastases requiring immediate palliative radiotherapy
* Evidence of spinal cord compression
* Bone metastases causing significant pain requiring opioid analgesics
* Oligometastatic disease suitable for radical treatment
* Leptomeningeal disease
* ECOG performance status ≥3
* Life expectancy less than 3 months
* Any condition that, in the investigator's opinion, would interfere with study participation or assessment

Conditions3

Bone MetastasesCancerMetastatic Solid Tumor

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.